Pages that link to "Item:Q538132"

The following pages link to The treatment versus experimentation dilemma in dose finding studies (Q538132):

Displaying 18 items.

• A conversation with Nancy Flournoy (Q254418) (← links)
• A note on continual reassessment method (Q274178) (← links)
• Optimal designs for contingent response models with application to toxicity-efficacy studies (Q389259) (← links)
• Information in a two-stage adaptive optimal design (Q389442) (← links)
• A note on the robustness of the continual reassessment method (Q433569) (← links)
• Response adaptive designs for phase II trials with binary endpoint based on context-dependent information measures (Q830089) (← links)
• Optimal sequential designs in phase I studies (Q1621308) (← links)
• Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
• Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule–Dose Regimes (Q2861956) (← links)
• The role of minimal sets in dose finding studies (Q4559466) (← links)
• Semiparametric Dose Finding Methods for Partially Ordered Drug Combinations (Q5041342) (← links)
• Adaptive Designs to Maximize Power in Clinical Trials with Multiple Treatments (Q5413553) (← links)
• Performance Measures in Dose‐Finding Experiments (Q6085864) (← links)
• A continual reassessment method without undue risk of toxicity (Q6171847) (← links)
• Evaluation of early phase dose finding algorithms in heterogeneous populations (Q6541920) (← links)
• A simulation-free approach to assessing the performance of the continual reassessment method (Q6617412) (← links)
• Improving safety of the continual reassessment method via a modified allocation rule (Q6627502) (← links)
• Rejoinder: ``Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies'' (Q6629390) (← links)